BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9424569)

  • 21. Observational studies and randomized trials.
    Kunz R; Khan KS; Neumayer HH
    N Engl J Med; 2000 Oct; 343(16):1194-5; author reply 1196-7. PubMed ID: 11041757
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials.
    Pildal J; Hróbjartsson A; Jørgensen KJ; Hilden J; Altman DG; Gøtzsche PC
    Int J Epidemiol; 2007 Aug; 36(4):847-57. PubMed ID: 17517809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deconstructing evidence in orthodontics: making sense of systematic reviews, randomized clinical trials, and meta-analyses.
    Rinchuse DJ; Rinchuse DJ; Kandasamy S; Ackerman MB
    World J Orthod; 2008; 9(2):167-76. PubMed ID: 18575311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.
    Dechartres A; Boutron I; Trinquart L; Charles P; Ravaud P
    Ann Intern Med; 2011 Jul; 155(1):39-51. PubMed ID: 21727292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trial sequential analyses of meta-analyses of complications in laparoscopic vs. small-incision cholecystectomy: more randomized patients are needed.
    Keus F; Wetterslev J; Gluud C; Gooszen HG; van Laarhoven CJ
    J Clin Epidemiol; 2010 Mar; 63(3):246-56. PubMed ID: 20004553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discrepancies between meta-analyses and subsequent large randomized, controlled trials.
    LeLorier J; Grégoire G; Benhaddad A; Lapierre J; Derderian F
    N Engl J Med; 1997 Aug; 337(8):536-42. PubMed ID: 9262498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Standardized mean differences in individually-randomized and cluster-randomized trials, with applications to meta-analysis.
    White IR; Thomas J
    Clin Trials; 2005; 2(2):141-51. PubMed ID: 16279136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the impact of attrition in randomized controlled trials.
    Hewitt CE; Kumaravel B; Dumville JC; Torgerson DJ;
    J Clin Epidemiol; 2010 Nov; 63(11):1264-70. PubMed ID: 20573482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graphical methods for detecting bias in meta-analysis.
    Ferrer RL
    Fam Med; 1998 Sep; 30(8):579-83. PubMed ID: 9773289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential and pitfalls of randomized clinical trials in cancer research.
    Buyse ME
    Cancer Surv; 1989; 8(1):91-105. PubMed ID: 2804990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revascularisation meta-analysis and randomisation.
    Austin J
    Anaesthesia; 2010 Feb; 65(2):211; author reply 211. PubMed ID: 20402852
    [No Abstract]   [Full Text] [Related]  

  • 32. Meta-analysis: an update.
    Sacks HS; Reitman D; Pagano D; Kupelnick B
    Mt Sinai J Med; 1996; 63(3-4):216-24. PubMed ID: 8692168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What randomized trials and systematic reviews can offer decision makers.
    Altman DG
    Horm Res; 1999; 51 Suppl 1():36-43. PubMed ID: 10393490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis: should it be more than the sum of its parts?
    Herbolsheimer P; Swain SM
    J Natl Cancer Inst; 2010 Dec; 102(24):1817-9. PubMed ID: 21098760
    [No Abstract]   [Full Text] [Related]  

  • 35. On ideals of objectivity, judgments, and bias in medical research - A comment on Stegenga.
    Jukola S
    Stud Hist Philos Biol Biomed Sci; 2017 Apr; 62():35-41. PubMed ID: 28188111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homoeopathy trials: going nowhere.
    Vandenbroucke JP
    Lancet; 1997 Sep; 350(9081):824. PubMed ID: 9310594
    [No Abstract]   [Full Text] [Related]  

  • 37. Mailed questionnaires: length matters.
    Edwards P
    J Public Health (Oxf); 2004 Jun; 26(2):214; author reply 214-5. PubMed ID: 15284329
    [No Abstract]   [Full Text] [Related]  

  • 38. Subjecting meta-analyses to closer scrutiny: Little support for differential efficacy among second-generation antipsychotics at equivalent doses.
    Tandon R; Nasrallah HA
    Arch Gen Psychiatry; 2006 Aug; 63(8):935-7; author reply 937-9. PubMed ID: 16894070
    [No Abstract]   [Full Text] [Related]  

  • 39. Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews.
    Vale CL; Tierney JF; Burdett S
    BMJ; 2013 Apr; 346():f1798. PubMed ID: 23610376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Are treatment effects or adverse effects of significance for the association between financing and conclusions in randomized trials?].
    Als-Nielsen BE; Chen W; Gluud CN; Gluud LL
    Ugeskr Laeger; 2004 Apr; 166(18):1676-8. PubMed ID: 15174406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.